Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 4c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.38), $0.04 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• PDD Holdings gains on second quarter earnings beat
• H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid